$63.65
0.85[1.35%]
At close: Apr 23
$63.65
0[0.00%]
After Hours: 4:00PM EDT
Bio-Techne
(NASDAQ:TECH)Bio-Techne Stock (NASDAQ:TECH), Analyst Ratings, Price Targets, Predictions
Bio-Techne Corp has a consensus price target of $137.43, established from looking at the 35 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, Stifel, and Stephens & Co. on April 18, 2024, February 2, 2024, and February 2, 2024. With an average price target of $78 between Deutsche Bank, Stifel, and Stephens & Co., there's an implied 22.55% upside for Bio-Techne Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Deutsche Bank
Stifel
Stephens & Co.
RBC Capital
UBS
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Bio-Techne
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/18/2024 | TECH | Buy Now | Bio-Techne | $63.65 | 28.83% | Deutsche Bank | Justin Bowers | $85 → $82 | Maintains | Buy | Get Alert |
| 02/02/2024 | TECH | Buy Now | Bio-Techne | $63.65 | 2.12% | Stifel | Daniel Arias | → $65 | Downgrade | Buy → Hold | Get Alert |
| 02/02/2024 | TECH | Buy Now | Bio-Techne | $63.65 | 36.68% | Stephens & Co. | Jacob Johnson | $92 → $87 | Maintains | Overweight | Get Alert |
| 02/02/2024 | TECH | Buy Now | Bio-Techne | $63.65 | 17.83% | RBC Capital | Conor McNamara | $85 → $75 | Maintains | Sector Perform | Get Alert |
| 12/07/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 25.69% | UBS | Dan Leonard | → $80 | Initiates | → Buy | Get Alert |
| 11/02/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 2.12% | Stifel | Daniel Arias | $104 → $65 | Maintains | Buy | Get Alert |
| 11/01/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 25.69% | Citigroup | Patrick Donnelly | $100 → $80 | Maintains | Buy | Get Alert |
| 11/01/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 30.4% | RBC Capital | Conor McNamara | $85 → $83 | Maintains | Sector Perform | Get Alert |
| 11/01/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 25.69% | Keybanc | Paul Knight | $115 → $80 | Maintains | Overweight | Get Alert |
| 09/12/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 35.11% | RBC Capital | Conor McNamara | → $86 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 08/28/2023 | TECH | Buy Now | Bio-Techne | $63.65 | — | William Blair | Matt Larew | — | Initiates | → Outperform | Get Alert |
| 08/18/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 88.53% | Benchmark | Robert Wasserman | → $120 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 57.11% | Stephens & Co. | Jacob Johnson | → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 05/04/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 41.4% | RBC Capital | Conor McNamara | $89 → $90 | Maintains | Sector Perform | Get Alert |
| 05/04/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 57.11% | Stephens & Co. | Jacob Johnson | → $100 | Reiterates | → Overweight | Get Alert |
| 05/04/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 57.11% | Baird | Catherine Schulte | $99 → $100 | Maintains | Outperform | Get Alert |
| 02/06/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 38.26% | RBC Capital | Conor McNamara | $89 → $88 | Maintains | Sector Perform | Get Alert |
| 02/03/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 88.53% | Benchmark | Robert Wasserman | → $120 | Maintains | Buy | Get Alert |
| 02/03/2023 | TECH | Buy Now | Bio-Techne | $63.65 | 72.82% | SVB Leerink | Puneet Souda | $125 → $110 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Bio-Techne (TECH)?
The latest price target for Bio-Techne (NASDAQ: TECH) was reported by Deutsche Bank on April 18, 2024. The analyst firm set a price target for $82.00 expecting TECH to rise to within 12 months (a possible 28.83% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bio-Techne (TECH)?
The latest analyst rating for Bio-Techne (NASDAQ: TECH) was provided by Deutsche Bank, and Bio-Techne maintained their buy rating.
When was the last upgrade for Bio-Techne (TECH)?
The last upgrade for Bio-Techne Corp happened on January 10, 2023 when Wells Fargo raised their price target to $90. Wells Fargo previously had an underweight for Bio-Techne Corp.
When was the last downgrade for Bio-Techne (TECH)?
The last downgrade for Bio-Techne Corp happened on February 2, 2024 when Stifel changed their price target from N/A to $65 for Bio-Techne Corp.
When is the next analyst rating going to be posted or updated for Bio-Techne (TECH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bio-Techne, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bio-Techne was filed on April 18, 2024 so you should expect the next rating to be made available sometime around April 18, 2025.
Is the Analyst Rating Bio-Techne (TECH) correct?
While ratings are subjective and will change, the latest Bio-Techne (TECH) rating was a maintained with a price target of $85.00 to $82.00. The current price Bio-Techne (TECH) is trading at is $63.65, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.